Innovation in Drug Development Clinical Trials in Africa
Download PresentationTowards Priority Reviews for Essential Medicines
Download PresentationStringent Regulatory Authority Collaborative Registration Procedure
Download PresentationEast African Community Medicines Regulatory Harmonization Project
Download PresentationSouthern Africa Business Forum Pharmaceuticals Working Group
Download PresentationWHO's role in Medicine Regulatory harmonization
Download PresentationEducation & Training needs & the Key Challenges in the Pharmaceutical Industry in SA
Download PresentationEast African Community Medicines Regulatory Harmonization Project
Download PresentationImproving Access through Local Production and Related Technology Transfer of Health Products
Download PresentationStrengthening the local production of essential medicines in developing and least developed countries
Download PresentationProduction of recombinant therapeutic proteins opportunities, challenges and possible – solutions
Download PresentationAccess To Essential Medicines In Africa
Download PresentationThe World Health Organization (WHO) introduced the concept of essential medicines in 1977. Essential medicines are intended to be available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality, and at a price the individual and the community can afford. They are selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost-effectiveness. In Africa, many countries have adopted the Essential Medicines List concept and embraced the principles of rational use of medicines. However there are critical challenges which this 2 day conference and exposition will seek to address. The areas of focus of PharmaConnect Africa (PharmaConnect-A) 2017 will be local pharmaceutical manufacturing, offshore procurement and distribution, and the over-arching role of medicine regulation along the whole value chain.
Read MoreSome regulators have started to give priority reviews to essential medicines in registration. However this is not matched with priority approvals of clinical trials. How can the priority approval…
Harmonization has long been talked about, but little progress seems to have been made in Africa because of factors including variable geometry, national sovereignty and language…
There is very little emphasis in the current pharmacy curricula in pharmalogistics, supply chain management and the attendant regulatory framework and quality management systems. Can short training programmes be developed and how can they be…
There has been de-industrialization in many African countries with global pharmaceutical companies retreating to global centres of excellence and the entry of Indian…
This conference is open to all who have an interest in the pharmaceutical industry in Africa. It will be of particular value to stakeholders in the pharmaceutical industry (human and animal health) , government officials, regulatory authorities, health care workers, non-state actors (NGOs) and researchers.